The rat tendon isn't your tendon
BPC-157 is a peptide: a short chain of amino acids, the building blocks of proteins. Much of its healing reputation comes from animal experiments. Researchers reported better recovery in cut rat Achilles tendons. That's a reason to investigate, but it doesn't show faster recovery in people.
For that, we need human studies with a fair comparison. What happened with other care? Were harms counted? A convincing story about how healing might work can't answer those questions on its own.
How small is the human evidence?
A review of muscle and joint research found only a few small human studies and a lack of large, rigorous trials. Its encouraging animal findings don't close that gap.
One early safety study involved two adults and reported no adverse events. Two people can tell us what happened to two people. They can't rule out uncommon harms or establish that an injury heals faster.
Safety is still an open question
Experiments found effects linked to new blood-vessel growth. That helps explain the interest in repair. It also raises a theoretical question about cancer, which depends on blood vessels too. This is a concern based on biology, not a finding that BPC-157 caused cancer in people.
Long-term human safety remains unclear. The review also flags uncertainty around material obtained outside controlled studies. A familiar name doesn't verify what's in a particular preparation.
The comparison page puts this gap beside the other topics. The missing answer is still whether people recover better, with an acceptable balance of benefit and harm.